
Sign up to save your podcasts
Or
Diana Morales, Founder and CEO of DM Consulting Services, brings over 25 years of experience in the bioprocess, cell, and gene therapy sectors, offering bespoke strategies for biotech startups and clinical drug development firms. At DM Consulting Services, Diana's leadership focuses on crafting robust commercial strategies and sales organizations for emerging companies, driving scientific innovations to market success with adaptability and a customer-centric approach.
Previously, Diana held significant roles at OrganaBio, Mass Biologics, and Invetech. At OrganaBio, she served as Vice President of Sales, where she played a pivotal role in advancing cGMP manufacturing services for cell-based therapies. As Vice President of Business Development and Operations at Mass Biologics, Diana contributed to the development and manufacturing of vaccines and biologics, emphasizing operational excellence in this historic institution. During her time at Invetech, Diana led the launch of new GMP products and services as VP, Head of Cell Therapy Products & Services. Her leadership in global management and team building significantly bolstered Invetech’s presence in the market.
5
11 ratings
Diana Morales, Founder and CEO of DM Consulting Services, brings over 25 years of experience in the bioprocess, cell, and gene therapy sectors, offering bespoke strategies for biotech startups and clinical drug development firms. At DM Consulting Services, Diana's leadership focuses on crafting robust commercial strategies and sales organizations for emerging companies, driving scientific innovations to market success with adaptability and a customer-centric approach.
Previously, Diana held significant roles at OrganaBio, Mass Biologics, and Invetech. At OrganaBio, she served as Vice President of Sales, where she played a pivotal role in advancing cGMP manufacturing services for cell-based therapies. As Vice President of Business Development and Operations at Mass Biologics, Diana contributed to the development and manufacturing of vaccines and biologics, emphasizing operational excellence in this historic institution. During her time at Invetech, Diana led the launch of new GMP products and services as VP, Head of Cell Therapy Products & Services. Her leadership in global management and team building significantly bolstered Invetech’s presence in the market.